Antibody selection is costing you more than you think
5
Min Read
In this blog:
- Antibody selection could be taking you nearly 100 hours a year
- Each failed experiment caused by using the wrong product? An estimated £2000 in reagent spend
- Millions of human and animal samples may be used with ineffective antibodies
Perhaps you’ve experienced the frustration of flitting between google, PubMed, third party databases and supplier datasheets to compile a shortlist of antibodies for your experiments.
You’ve almost certainly felt the frustration when the reagent you eventually pick doesn’t work.
What you may not have considered, is some of the more hidden costs associated with these two intrinsically connected problems.
Today, we show you all the areas you may be losing time, budget and precious samples during antibody selection, and how you can optimise the process to reduce risk to your research throughout.
The hidden costs in selecting antibodies
Selecting research antibodies is an essential first step in many experiments: IHC,WB, Flow Cytometry, the list goes on. However, finding the right one from a pool of 10 million certainly isn’t a quick or easy job.
Every hour spent switching between sources to gather information is an hour not spent at the bench. Scientists could pull from all of the following to make just one informed antibody choice:
- Google: An initial search for available reagents (sponsored placements often skewing results)
- PubMed: Manually reading papers to confirm reagent use in relevant experiments
- Supplier sites: Cross-referencing products across multiple companies, and checking datasheets for validation and experimental information
- Third-party sites: Sourcing additional data, such as validation data from YCharOS
- Internal data: Sifting through unstructured protocol and experimental records
What this actually costs you
Conservative estimates put this search process at around 1-2 hours per product.
If you’re sourcing just one reagent a week and spending 2 hours doing so, that adds up to nearly 100 hours in a working year. [1]
In budget terms, that’s around £5,000 per researcher, per year, at an average researcher cost – before you’ve even run the experiment.
The company-wide cost
Time spent finding reagents and troubleshooting is time that isn’t spent on research to bring a new therapy to market; and across an organisation, this scales quickly.
For example, a company of 500 researchers could spent 46,000 hours annually searching for antibodies.
The compounding effect – running experiments with the wrong antibody
Time and budget lost
Searching for an antibody is only half the battle. Even after you’ve gone through the lengthy process of shortlisting candidates, if the antibody you land on isn’t specific to your target, in your application, the result is failed and irreproducible experiments. This can equate to an estimated:
- ~10 hours of research time lost per failed experiment
- ~£2,000 in wasted budget per experiment in material spend
Even if the science, experimental execution and record-keeping is all correct, if the underlying reagent isn’t right, delays are inevitable.
The human and animal cost
The cost to valuable human and patient samples is even more concerning.
A recent paper by Biddle et al. estimated that 6 million human samples and 4 million animal samples may have been used with antibodies that failed knockout (KO) validation testing, with no validation data presented in the published work. [2]
Broken down per paper lacking validation, this works out to roughly 7 human samples and 13 animal samples.
These may be rare and unique samples from patients that cannot be recovered.
The drug pipeline cost
When research fails at the first step, the reruns and restarts that follow can slow a drug discovery programme down.
Over time, lost experiments and wasted samples can affect how quickly the right drugs reach patients.
How CiteAb can help address the hidden costs
The CiteAb search engine compiles reagent usage data in one place: 18 million products (including antibodies, kits, models, proteins and more) ranked by citations; supplier data, published images, links to YCharOS independent validation data; and the opportunity to add private comments to product pages, shared with your team. Independent benchmarking found a reduction in time to shortlist by an estimated 45%. [1]
Scientists can filter by recombinant or KO-validated products, application, and other factors that matter for reproducibility – helping to choose the right fit, faster, and reducing the compounding effect of running experiments with the wrong product.
Wrap-up
Every scientist wants the same thing: the right reagent, found efficiently, that works as expected the first time.
But the true cost of antibody selection is often much higher than it appears, in hours, in budget, and in samples you can’t replace.
- ~2 hours spent finding the reagent
- An estimated ~10 hours, £2,000 and precious samples wasted when it fails to work
- A restarted search to repurchase products and redo experiments
Try a search on CiteAb today to see how we can help in this challenge.
References
[1]Baselines Assumptions:
| Parameter | Value | Source |
|---|---|---|
| Time-to-shortlist reduction | 45% | Top 5 Pharma evaluation |
| Avg. time per reagent search session | 2 hours | Conservative industry estimate |
| Avg. searches per user per week | 1 | Conservative estimate |
| Reduction in failed experiments per user | 2 | Conservative estimate |
| Avg. time per saved experiment | 10 hours | Conservative estimate |
| Working weeks per year | 46 | Adjusted for leave/downtime |
| Avg. fully-loaded researcher cost | £60/hour | UK pharma benchmark |
2. Biddle et al. 2026 – Drivers and ethical impacts of insufficient validation of antibodies in research https://www.biorxiv.org/content/10.64898/2026.02.19.706766v1
